Mario Schlosser Sells 600,000 Shares of Oscar Health (NYSE:OSCR) Stock

Oscar Health, Inc. (NYSE:OSCR) Director Mario Schlosser sold 600,000 shares of the company’s stock in a transaction dated Thursday, August 27th. The shares were sold at an average price of $30.34, for a total transaction of $18,204,000.00. Following the sale, the director directly owned 480,866 shares of the company’s stock, valued at $14,589,474.44. The trade was a 55.51% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website.

Mario Schlosser also recently made the following trade(s):

• On Friday, August 28th, Mario Schlosser sold 150,000 shares of Oscar Health stock. The stock was sold at an average price of $30.79, for a total transaction of $4,618,500.00.
• On Tuesday, June 23rd, Mario Schlosser sold 147,500 shares of Oscar Health stock. The stock was sold at an average price of $29.38, for a total transaction of $4,333,550.00.
• On Tuesday, June 23rd, Mario Schlosser sold 880,000 shares of Oscar Health stock. The shares were sold at an average price of $29.38, for a total transaction of $25,854,400.00.
• On Tuesday, June 2nd, Mario Schlosser sold 34,120 shares of Oscar Health stock. The shares were sold at an average price of $21.94, for a total transaction of $748,592.80.

Oscar Health Stock Performance

OSCR stock traded down $0.47 during midday trading on Monday, reaching $30.00. 3,638,656 shares of the company’s stock traded hands, compared to its average volume of 7,137,195. The company has a current ratio of 1.09, a quick ratio of 1.09 and a debt-to-equity ratio of 0.21. Oscar Health, Inc. has a 52-week low of $10.69 and a 52-week high of $33.55. The stock has a market cap of $9.26 billion, a P/E ratio of 21.43, a PEG ratio of 0.63 and a beta of 2.36. The stock’s 50-day moving average is $30.27 and its 200 day moving average is $22.13.

Oscar Health (NYSE:OSCR) last issued its quarterly earnings results on Thursday, August 6th. The company reported $1.10 earnings per share for the quarter, topping the consensus estimate of $0.40 by $0.70. The business had revenue of $4.88 billion for the quarter, compared to analysts’ expectations of $4.73 billion. Oscar Health had a net margin of 3.60% and a return on equity of 38.45%. The company’s revenue was up 70.4% compared to the same quarter last year. During the same quarter last year, the company posted ($0.89) EPS. As a group, analysts anticipate that Oscar Health, Inc. will post 1.54 EPS for the current year.

Hedge Funds Weigh In On Oscar Health

A number of hedge funds have recently bought and sold shares of the business. California State Teachers Retirement System grew its holdings in Oscar Health by 3,214.2% in the 2nd quarter. California State Teachers Retirement System now owns 7,803,043 shares of the company’s stock valued at $222,543,000 after buying an additional 7,567,600 shares during the period. BIT Capital GmbH lifted its stake in shares of Oscar Health by 545.0% during the fourth quarter. BIT Capital GmbH now owns 6,186,267 shares of the company’s stock worth $88,897,000 after purchasing an additional 5,227,152 shares in the last quarter. Morgan Stanley boosted its holdings in Oscar Health by 42.8% in the 4th quarter. Morgan Stanley now owns 6,814,046 shares of the company’s stock worth $97,918,000 after acquiring an additional 2,043,758 shares during the period. Bank of America Corp DE grew its holdings in Oscar Health by 205.1% during the 1st quarter. Bank of America Corp DE now owns 2,860,310 shares of the company’s stock valued at $32,808,000 after purchasing an additional 1,922,732 shares in the last quarter. Finally, Thrive Capital Management LLC grew its stake in shares of Oscar Health by 33.4% during the fourth quarter. Thrive Capital Management LLC now owns 6,343,617 shares of the company’s stock valued at $85,258,000 after acquiring an additional 1,588,395 shares in the last quarter. Hedge funds and other institutional investors own 75.70% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of brokerages recently issued reports on OSCR. The Goldman Sachs Group reissued a “neutral” rating and issued a $30.00 target price on shares of Oscar Health in a research report on Tuesday, August 11th. Wolfe Research initiated coverage on shares of Oscar Health in a research note on Tuesday, May 5th. They issued a “peer perform” rating for the company. Robert W. Baird set a $27.00 price target on shares of Oscar Health in a research report on Friday, August 7th. Piper Sandler reissued an “overweight” rating and issued a $36.00 price objective on shares of Oscar Health in a research report on Tuesday, July 28th. Finally, Wall Street Zen upgraded shares of Oscar Health from a “buy” rating to a “strong-buy” rating in a research note on Sunday, June 14th. One analyst has rated the stock with a Strong Buy rating, three have given a Buy rating and eight have issued a Hold rating to the stock. According to data from MarketBeat, the company has a consensus rating of “Hold” and an average price target of $26.22.

Oscar Health Company Profile

Oscar Health, trading on the New York Stock Exchange under the ticker OSCR, is a technology-driven health insurance company headquartered in New York, New York. Founded in 2012 by Mario Schlosser, Joshua Kushner and Kevin Nazemi, the company was built with the goal of simplifying healthcare coverage and enhancing member experience. Oscar leverages a proprietary digital platform to streamline plan enrollment, claims administration and member support, distinguishing itself in the individual, family and small group insurance markets.

The company’s primary products include on-exchange individual and family medical plans under the Affordable Care Act, off-exchange plans, as well as Medicare Advantage offerings.